{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:04:16Z","timestamp":1790978656831,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["2024-EKEA.126"],"award-info":[{"award-number":["2024-EKEA.126"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ebiom.2025.105930","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T07:10:48Z","timestamp":1758611448000},"page":"105930","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Comparative analysis of cerebrospinal fluid neurofilament medium, light and heavy chain in neurodegenerative diseases using an in-house assay for the detection of neurofilament medium chain"],"prefix":"10.1016","volume":"120","author":[{"given":"Badrieh","family":"Fazeli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Botzenhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Bachhuber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Klassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Klose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Dorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Wiesenfarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeljko","family":"Uzelac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Jesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Anderl-Straub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert C.","family":"Ludolph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Otto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Weishaupt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayrettin","family":"Tumani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8711-5702","authenticated-orcid":false,"given":"Steffen","family":"Halbgebauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2025.105930_bib1","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1093\/brain\/awaa098","article-title":"Neurofilaments: Neurobiological foundations for biomarker applications","volume":"143","author":"Gafson","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.ebiom.2025.105930_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.689938","article-title":"Neurofilament proteins as biomarkers to monitor neurological diseases and the efficacy of therapies","volume":"15","author":"Yuan","year":"2021","journal-title":"Front Neurosci"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105930_bib3","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1038\/s41380-024-02524-6","article-title":"Introducing neurofilament light chain measure in psychiatry: current evidence, opportunities, and pitfalls","volume":"29","author":"Bavato","year":"2024","journal-title":"Mol Psychiatry"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105930_bib4","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a018309","article-title":"Neurofilaments and neurofilament proteins in health and disease","volume":"9","author":"Yuan","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105930_bib5","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1515\/cclm-2020-1276","article-title":"Biological variation of serum neurofilament light chain","volume":"60","author":"Hviid","year":"2022","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.ebiom.2025.105930_bib6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41582-024-00955-x","article-title":"Neurofilaments as biomarkers in neurological disorders \u2014 towards clinical application","volume":"20","author":"Khalil","year":"2024","journal-title":"Nat Reviews Neurology"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105930_bib7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/ana.24980","article-title":"Phosphorylated neurofilament heavy chain: a biomarker of survival for C9ORF72-associated amyotrophic lateral sclerosis","volume":"82","author":"Gendron","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ebiom.2025.105930_bib8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.conb.2020.02.001","article-title":"Neurofilaments in disease: what do we know?","volume":"61","author":"Gordon","year":"2020","journal-title":"Curr Opin Neurobiol"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105930_bib9","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcae288","article-title":"Comparative analysis of neurofilaments and biomarkers of muscular damage in amyotrophic lateral sclerosis","volume":"6","author":"Vidovic","year":"2024","journal-title":"Brain Commun"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105930_bib10","doi-asserted-by":"crossref","first-page":"22128","DOI":"10.1038\/s41598-021-01499-6","article-title":"Neurofilaments can differentiate ALS subgroups and ALS from common diagnostic mimics","volume":"11","author":"Behzadi","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.ebiom.2025.105930_bib11","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.dadm.2019.08.009","article-title":"The diagnostic performance of neurofilament light chain in CSF and blood for Alzheimer's disease, frontotemporal dementia, and amyotrophic lateral sclerosis: a systematic review and meta-analysis","volume":"11","author":"Forgrave","year":"2019","journal-title":"Alzheimers Dementia (Amst)"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105930_bib12","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/jnnp-2021-327129","article-title":"Comparison of CSF and serum neurofilament light and heavy chain as differential diagnostic biomarkers for ALS","volume":"93","author":"Halbgebauer","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105930_bib13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1001\/jamaneurol.2015.3037","article-title":"Association of cerebrospinal fluid neurofilament light concentration with Alzheimer disease progression","volume":"73","author":"Zetterberg","year":"2016","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105930_bib14","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16089","article-title":"Plasma neurofilament light chain predicts Alzheimer's disease in patients with subjective cognitive decline and mild cognitive impairment: a cross-sectional and longitudinal study","volume":"31","author":"Mazzeo","year":"2024","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.ebiom.2025.105930_bib15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/brain\/awad267","article-title":"The potential of blood neurofilament light as a marker of neurodegeneration for Alzheimer's disease","volume":"147","author":"Jung","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.ebiom.2025.105930_bib16","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s40520-020-01554-8","article-title":"The role of neurofilament light chain in frontotemporal dementia: a meta-analysis","volume":"33","author":"Karantali","year":"2021","journal-title":"Aging Clin Experimental Res"},{"key":"10.1016\/j.ebiom.2025.105930_bib17","doi-asserted-by":"crossref","first-page":"679199","DOI":"10.3389\/fnins.2021.679199","article-title":"Neurofilament light chain as biomarker for amyotrophic lateral sclerosis and frontotemporal dementia","volume":"15","author":"Verde","year":"2021","journal-title":"Front Neurosci"},{"key":"10.1016\/j.ebiom.2025.105930_bib18","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1471-2377-13-54","article-title":"Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia","volume":"13","author":"Landqvist Wald\u00f6","year":"2013","journal-title":"BMC Neurol"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105930_bib19","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3233\/JAD-210342","article-title":"Plasma neurofilament light chain predicts cognitive progression in prodromal and clinical dementia with lewy bodies","volume":"82","author":"Pilotto","year":"2021","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105930_bib20","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s13195-024-01593-7","article-title":"Plasma neurofilament light chain as prognostic marker of cognitive decline in neurodegenerative diseases, a clinical setting study","volume":"16","author":"G\u00f6tze","year":"2024","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105930_bib21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13024-021-00499-4","article-title":"A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study","volume":"16","author":"Bergstr\u00f6m","year":"2021","journal-title":"Mol Neurodegener"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105930_bib22","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1136\/jnnp-2019-322476","article-title":"Different CSF protein profiles in amyotrophic lateral sclerosis and frontotemporal dementia with C9orf72 hexanucleotide repeat expansion","volume":"91","author":"Barschke","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105930_bib23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40035-020-00198-y","article-title":"Altered levels of CSF proteins in patients with FTD, presymptomatic mutation carriers and non-carriers","volume":"9","author":"Remnest\u00e5l","year":"2020","journal-title":"Transl Neurodegener"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105930_bib24","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/acn3.83","article-title":"Plasma profiling reveals three proteins associated to amyotrophic lateral sclerosis","volume":"1","author":"H\u00e4ggmark","year":"2014","journal-title":"Ann Clin Transl Neurol"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105930_bib25","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/jnc.14542","article-title":"A motor neuron strategy to save time and energy in neurodegeneration: adaptive protein stoichiometry","volume":"146","author":"Zucchi","year":"2018","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105930_bib26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00401-019-02093-x","article-title":"Proteomics in cerebrospinal fluid and spinal cord suggests UCHL1, MAP2 and GPNMB as biomarkers and underpins importance of transcriptional pathways in amyotrophic lateral sclerosis","volume":"139","author":"Oeckl","year":"2020","journal-title":"Acta Neuropathol"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105930_bib27","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/146608200300079536","article-title":"El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis","volume":"1","author":"Brooks","year":"2000","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105930_bib28","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.1007\/s00415-024-12348-7","article-title":"Amyotrophic lateral sclerosis stratification: unveiling patterns with virome, inflammation, and metabolism molecules","volume":"271","author":"Niccolai","year":"2024","journal-title":"J Neurol"},{"key":"10.1016\/j.ebiom.2025.105930_bib29","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S1474-4422(21)00066-1","article-title":"Clinical diagnosis of Alzheimer's disease: recommendations of the international working group","volume":"20","author":"Dubois","year":"2021","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.ebiom.2025.105930_bib30","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dementia"},{"issue":"9","key":"10.1016\/j.ebiom.2025.105930_bib31","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/brain\/awr179","article-title":"Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia","volume":"134","author":"Rascovsky","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.ebiom.2025.105930_bib32","author":"Gorno-Tempini"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105930_bib33","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ebiom.2025.105930_bib34","series-title":"Diagnostic and statistical manual of mental disorders: primary care version","article-title":"Diagnostic and statistical manual of mental disorders: primary care version, 4th ed","year":"1995"},{"key":"10.1016\/j.ebiom.2025.105930_bib35","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/mds.21507","article-title":"Clinical diagnostic criteria for dementia associated with Parkinson's disease","volume":"22","author":"Emre","year":"2007","journal-title":"Mov Disord"},{"issue":"22","key":"10.1016\/j.ebiom.2025.105930_bib36","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1212\/WNL.0b013e3181c47cc2","article-title":"A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking","volume":"73","author":"Teunissen","year":"2009","journal-title":"Neurology"},{"issue":"Aug","key":"10.1016\/j.ebiom.2025.105930_bib37","first-page":"179","article-title":"A practical guide to immunoassay method validation","volume":"6","author":"Andreasson","year":"2015","journal-title":"Front Neurol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105930_bib38","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1037\/a0024338","article-title":"Effect size estimates: current use, calculations, and interpretation","volume":"141","author":"Fritz","year":"2012","journal-title":"J Exp Psychol Gen"},{"key":"10.1016\/j.ebiom.2025.105930_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.106166","article-title":"Neurofilament light in serum: reference values and effect of risk factors for multiple sclerosis","volume":"92","author":"S\u00f8ndergaard","year":"2024","journal-title":"Mult Scler Relat Disord"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105930_bib40","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00415-025-13271-1","article-title":"Neurofilament light chain reference values in serum and cerebrospinal fluid: a bi-compartmental analysis in neurological diseases","volume":"272","author":"Halbgebauer","year":"2025","journal-title":"J Neurol"},{"issue":"10","key":"10.1016\/j.ebiom.2025.105930_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164625","article-title":"Neurofilaments as biomarkers for amyotrophic lateral sclerosis: a systematic review and meta-analysis","volume":"11","author":"Xu","year":"2016","journal-title":"PLoS One"},{"issue":"1\u20132","key":"10.1016\/j.ebiom.2025.105930_bib42","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/21678421.2024.2428930","article-title":"Cerebrospinal fluid levels of NfM in relation to NfL and pNfH as prognostic markers in amyotrophic lateral sclerosis","volume":"26","author":"Olofsson","year":"2025","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105930_bib43","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1001\/jamaneurol.2016.5398","article-title":"Diagnostic and prognostic biomarkers in amyotrophic lateral sclerosis: neurofilament light chain levels in definite subtypes of disease","volume":"74","author":"Gaiani","year":"2017","journal-title":"JAMA Neurol"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105930_bib44","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/jnnp-2014-307672","article-title":"Plasma neurofilament heavy chain levels and disease progression in amyotrophic lateral sclerosis: insights from a longitudinal study","volume":"86","author":"Lu","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5\u20136","key":"10.1016\/j.ebiom.2025.105930_bib45","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000091436","article-title":"The neurofilament heavy chain (NfHSMI35) in the cerebrospinal fluid diagnosis of Alzheimer's disease","volume":"21","author":"Brettschneider","year":"2006","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105930_bib46","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.neurobiolaging.2011.05.013","article-title":"Serial CSF sampling in Alzheimer's disease: specific versus non-specific markers","volume":"33","author":"Kester","year":"2012","journal-title":"Neurobiol Aging"},{"issue":"1\u20132","key":"10.1016\/j.ebiom.2025.105930_bib47","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jneuroim.2010.01.004","article-title":"A highly sensitive electrochemiluminescence immunoassay for the neurofilament heavy chain protein","volume":"220","author":"Kuhle","year":"2010","journal-title":"J Neuroimmunol"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105930_bib48","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000099473","article-title":"CSF neurofilaments in frontotemporal dementia compared with early onset Alzheimer's disease and controls","volume":"23","author":"Pijnenburg","year":"2007","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105930_bib49","first-page":"12","article-title":"Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients","volume":"87","author":"Steinacker","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"24","key":"10.1016\/j.ebiom.2025.105930_bib50","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1212\/WNL.0000000000004029","article-title":"Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease","volume":"88","author":"Poesen","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.ebiom.2025.105930_bib51","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S1359-0294(03)00010-4","article-title":"Assembly and structure of neurofilaments","volume":"8","author":"Janmey","year":"2003","journal-title":"Curr Opin Colloid Interface Sci"},{"key":"10.1016\/j.ebiom.2025.105930_bib52","author":"Steinacker"},{"issue":"2","key":"10.1016\/j.ebiom.2025.105930_bib53","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41591-018-0304-3","article-title":"Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease","volume":"25","author":"Preische","year":"2019","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105930_bib54","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neuron.2016.05.018","article-title":"Neurofilament light chain in blood and CSF as marker of disease progression in mouse models and in neurodegenerative diseases","volume":"91","author":"Bacioglu","year":"2016","journal-title":"Neuron"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105930_bib55","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","article-title":"Neurofilament light chain as a biomarker in neurological disorders","volume":"90","author":"Gaetani","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425003743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425003743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T17:37:33Z","timestamp":1772905053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396425003743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":55,"alternative-id":["S2352396425003743"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105930","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative analysis of cerebrospinal fluid neurofilament medium, light and heavy chain in neurodegenerative diseases using an in-house assay for the detection of neurofilament medium chain","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105930","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105930"}}